NCT01594372

Brief Summary

Investigators intend to conduct a prospective randomized trial to compare vaginal hysterectomy with uterosacral colposuspension to laparoscopic supracervical hysterectomy with sacrocervicopexy. Both surgeries are minimally-invasive surgical standards of care for uterine prolapse repair. Nobody knows if one procedure is superior to the other, as they have not been compared directly. The investigators hypothesize that there is no difference in objective, subjective, or cost-effectiveness between the two procedures for up to two years after surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 4, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 9, 2012

Completed
8 months until next milestone

Study Start

First participant enrolled

January 1, 2013

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2015

Completed
Last Updated

March 4, 2022

Status Verified

March 1, 2022

Enrollment Period

2.3 years

First QC Date

May 4, 2012

Last Update Submit

March 2, 2022

Conditions

Keywords

Uterine ProlapseLaparoscopyHysterectomy, vaginal

Outcome Measures

Primary Outcomes (3)

  • Whether or not POPQ points AA, BA, Ap, or Bp are at less than 0 cm from the hymen OR whether point C descends less than 1/3 of the total vaginal length (TVL)

    24 months

  • Absence of re-treatment for prolapse at 2 years

    24 months

  • A negative response to "Do you usually have a bulge or something falling out that you can see or feel in the vaginal area?"

    This is a question from the standardized questionnaire called Pelvic Floor Discomfort Inventory (PFDI).

    24 months

Secondary Outcomes (4)

  • Changes in POPQ measurements

    baseline, 6 week, and 3, 12, and 24 months

  • Changes in Patient-reported quality of life scores from the EQ-5D, PFDI, PFIQ, SF-12, Standard Gamble Interview, Pain Scale and Activity Assessment

    baseline, 3, 12, and 24 months

  • Change in patient reported sexual questionnaire, PISQ

    baseline, 3, 12 and 24 months

  • Frequencies of surgical and post-operative complications

    up to 2 years post-operatively

Study Arms (2)

Laparoscopic Repair

ACTIVE COMPARATOR

Laparoscopic supracervical hysterectomy with sacropexy

Procedure: Laparoscopic supracervical hysterectomy with sacropexy

Vaginal Repair

ACTIVE COMPARATOR

Vaginal hysterectomy with uterosacral colposuspension

Procedure: Vaginal hysterectomy with uterosacral colposuspension

Interventions

Will involve laparoscopic entry to the abdomen to remove the uterus and suspension of the cervix and vaginal cuff to the sacrum with mesh. We will allow surgeons to conduct the surgery as they have perfected it

Laparoscopic Repair

Will involve removing the uterus vaginally followed by suspending the vaginal cuff to the high (proximal) uterosacral ligaments bilaterally restoring the vagina to its normal axis.

Vaginal Repair

Eligibility Criteria

Age18 Years - 100 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with primary symptomatic uterine prolapse
  • ≥ 18 years of age
  • Considering pelvic reconstructive surgery

You may not qualify if:

  • Unwillingness to be randomized to one of two surgical approaches
  • Pregnant or planning to maintain their future fertility
  • Unable to have general anesthesia
  • Currently undergoing chemotherapy OR has current or history of pelvic radiation
  • Previous adverse reaction to synthetic mesh
  • Recent history of abnormal paps (past 10 years)
  • Cervical or uterine cancers
  • Previous hysterectomy
  • Previous central vault or uterine prolapse repair
  • Uterus ≥ 14 weeks size
  • Uterine cancer
  • History of significant pelvic adhesive disease
  • Elongated cervix (length D to C \> 6cm)
  • Fibroid ≥ 7cm
  • Post menopausal with enlarged uterus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brigham And Women's Hospital

Boston, Massachusetts, 02115, United States

Location

MeSH Terms

Conditions

Uterine Prolapse

Interventions

Hysterectomy, Vaginal

Condition Hierarchy (Ancestors)

Uterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesPelvic Organ ProlapseProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

HysterectomyGynecologic Surgical ProceduresUrogenital Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Vatche A Minassian, MD, MPH

    Brigham and Women's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Urogynecology

Study Record Dates

First Submitted

May 4, 2012

First Posted

May 9, 2012

Study Start

January 1, 2013

Primary Completion

May 1, 2015

Study Completion

May 1, 2015

Last Updated

March 4, 2022

Record last verified: 2022-03

Locations